Omega-3 fatty acids and risk of cognitive decline in the elderly: a meta-analysis of randomized controlled trials

Aging Clinical and Experimental Research

Volumn 28, Issue 1, 2016, Pages 165-166

  Zhang, Xiao Wei ^a   Hou, Wen Shang ^a   Li, Min ^a   Tang, Zhen Yu ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Cognitive decline; Meta analysis; Omega 3 fatty acids; Randomized controlled trial

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

AGED; ARTICLE; COGNITIVE DEFECT; DIET SUPPLEMENTATION; HUMAN; META ANALYSIS; MINI MENTAL STATE EXAMINATION; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SYSTEMATIC REVIEW; COGNITION DISORDERS; INTELLIGENCE TEST; METABOLISM; TREATMENT OUTCOME;

AGED; COGNITION DISORDERS; FATTY ACIDS, OMEGA-3; HUMANS; INTELLIGENCE TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 84962091293     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/s40520-015-0381-9     Document Type: Article

References (15)

1. Waitzberg DL, Garla P (2014) Contribution of omega-3 fatty acids for memory and cognitive function. Nutr Hosp 30(3):467–477
2. Hooijmans CR, Kiliaan AJ (2008) Fatty acids, lipid metabolism and Alzheimer pathology. Eur J Pharmacol 585(1):176–196
3. Uauy R, Dangour AD (2006) Nutrition in brain development and aging: role of essential fatty acids. Nutr Rev 64(5 Pt 2):S24–S33 discussion S72–S91
4. Rondanelli M, Opizzi A, Faliva M et al (2012) Effects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairment. Nutr Neurosci 15:46–54
5. Geleijnse JM, Giltay EJ, Kromhout D (2012) Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients. Alzheimers Dement 8:278–287
6. Lee LK, Shahar S, Chin AV et al (2013) Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, doubleblind, placebo-controlled trial. Psychopharmacology (Berl) 225:605–612
7. Yurko-Mauro K, McCarthy D, Rom D et al (2010) Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 6:456–464
8. Chiu CC, Su KP, Cheng TC et al (2008) The effects of omega-3 fatty acids monotherapy in Alzheimer’s disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry 32:1538–1544
9. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T et al (2006) Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: omegAD study: a randomized double-blind trial. Arch Neurol 63:1402–1408
10. Dangour AD, Allen E, Elbourne D et al (2010) Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am J Clin Nutr 91:1725–1732
11. Stough C, Downey L, Silber B et al (2012) The effects of 90-day supplementation with the omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population. Neurobiol Aging 33:824
12. Shinto L, Quinn J, Montine T et al (2014) A Randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer’s disease. J Alzheimers Dis 38(1):111–120
13. Dyall SC, Michael GJ, Michael-Titus AT (2010) Omega-3 fatty acids reverse age-related decreases in nuclear receptors and increase neurogenesis in old rats. J Neurosci Res 88(10):2091–2102
14. Robson LG, Dyall S, Sidloff D et al (2010) Omega-3 polyunsaturated fatty acids increase the neurite outgrowth of rat sensory neurones throughout development and in aged animals. Neurobiol Aging 31(4):678–687
15. Cutuli D, De Bartolo P, Caporali P et al (2014) n-3 polyunsaturated fatty acids supplementation enhances hippocampal functionality in aged mice. Front Aging Neurosci 6:220